Top news of the day from across the health care landscape
Allergan announced positive topline results from CGP-MD-01, a phase 2b/3 clinical trial of atogepant.
Specialty drugs with limited distribution networks require pharmacies to put together an extensive request for proposal to gain access.
Top news of the day from across the health care landscape
The researchers found that total duration of opioid use was the strongest predictor of misuse, with each refill and additional week of opioid use associated with an increased rate of misuse.
Officials with the FDA have granted GBC0905, for the treatment of facioscapulohumeral muscular dystrophy (FSHD), an Orphan Drug Designation.
Patients with both private and public insurers face high denial rates across the United States for life-saving hepatitis C drugs, despite changes in restrictions and increased price competition.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.